Immix Biopharma, Inc. (IMMX) Executive Compensation
Immix Biopharma, Inc. (IMMX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMMX
CIK: 1873835
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Crowe LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerGlenn Richards
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-30 | 2026-09-29 | 8-K | 0001493152-26-045143 | View SEC Doc Filr Page |
| FWP | 2026-09-29 | — | FWP | 0001493152-26-044774 | View SEC Doc Filr Page |
| 424B5 | 2026-09-29 | — | 424B5 | 0001493152-26-044771 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001493152-26-044761 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001580642-26-005295 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000202 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001493152-26-036643 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | 8-K | 0001493152-26-033829 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-05 | — | SCHEDULE 13G/A Filing | 0001274173-26-000156 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-22 | 8-K | 0001493152-26-026431 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026429 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026430 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026427 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026428 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026426 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026425 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026424 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026422 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-22 | 4 | 0001493152-26-026423 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | 8-K | 0001493152-26-024872 | View SEC Doc Filr Page |
| 424B5 | 2026-05-21 | — | 424B5 | 0001493152-26-024869 | View SEC Doc Filr Page |
| FWP | 2026-05-21 | — | FWP | 0001493152-26-024715 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | 8-K | 0001493152-26-024707 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001274173-26-000146 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001493152-26-021764 | View SEC Doc Filr Page |